{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T04:20:53Z","timestamp":1774585253912,"version":"3.50.1"},"reference-count":34,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"unspecified","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2022,6,21]]},"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Pulmonary hypertension (PH) is a progressive disease of the pulmonary vasculature, which is characterised by premature morbidity and mortality. The aim of this study is to define the characteristics of PH in the national PH unit (NPHU) in Ireland between 2010 and 2020.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Cases of PH which were referred to the NPHU between 2010 and 2020 were included. PH was defined as a mean pulmonary artery pressure \u226525 mm Hg at right heart catheterisation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Four hundred and fifteen cases of PH were identified during the study period. Group 1 pulmonary arterial hypertension (PAH) accounted for 39% (n=163) of cases, with a calculated annual incidence of 3.11 per million population (95% CI 1.53 to 4.70). The leading PAH subgroup was connective tissue disease-associated PAH (CTD-PAH), which was responsible for 49% of PAH referrals. This was followed by idiopathic PAH, with an estimated annual incidence of 0.63 cases per million population. The mean age at PAH diagnosis was 56\u00b115 years and 86% (n=111) received double-combination or triple-combination therapy within the first 12 months of diagnosis. The 1-year, 3-year and 5-year transplant-free survival for PAH was 89%, 75% and 65%. This was significantly lower for individuals with CTD-PAH relative to other PAH subgroups (p&lt;0.05).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>This study describes the incidence and outcomes of PH in Ireland. While the outcomes are comparable to other centres, the incidence of PAH and specific subgroups appears low, suggesting that improved disease awareness and case recognition are required. Furthermore, the survival of individuals with CTD-PAH is poor and requires additional exploration.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjresp-2022-001272","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T11:45:15Z","timestamp":1656503115000},"page":"e001272","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Incidence and outcomes of pulmonary hypertension in the Ireland"],"prefix":"10.1136","volume":"9","author":[{"given":"Sarah","family":"Cullivan","sequence":"first","affiliation":[{"name":"National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Lennon","sequence":"additional","affiliation":[{"name":"National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salima","family":"Meghani","sequence":"additional","affiliation":[{"name":"National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitriona","family":"Minnock","sequence":"additional","affiliation":[{"name":"National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"McCullagh","sequence":"additional","affiliation":[{"name":"National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Gaine","sequence":"additional","affiliation":[{"name":"National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"2025083112420304000_9.1.e001272.1","doi-asserted-by":"crossref","first-page":"L992","DOI":"10.1152\/ajplung.00098.2020","article-title":"Call it by the correct name-pulmonary hypertension not pulmonary arterial hypertension: growing recognition of the global health impact for a well-recognized condition and the role of the pulmonary vascular research Institute","volume":"318","author":"Corris","year":"2020","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2025083112420304000_9.1.e001272.2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S2213-2600(15)00543-3","article-title":"A global view of pulmonary hypertension","volume":"4","author":"Hoeper","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2025083112420304000_9.1.e001272.3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01913-2018"},{"key":"2025083112420304000_9.1.e001272.4","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201203-0383OC"},{"key":"2025083112420304000_9.1.e001272.5","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01887-2018","article-title":"Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives","volume":"53","author":"Humbert","year":"2019","journal-title":"Eur Respir J"},{"key":"2025083112420304000_9.1.e001272.6","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0120-2017"},{"key":"2025083112420304000_9.1.e001272.7","unstructured":"Central Statistics Office, G.o.I . Census of population; 2016."},{"key":"2025083112420304000_9.1.e001272.8","unstructured":"Tenny S BS . Incidence. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2022."},{"key":"2025083112420304000_9.1.e001272.9","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01032-2015"},{"key":"2025083112420304000_9.1.e001272.10","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2017.09.14"},{"key":"2025083112420304000_9.1.e001272.11","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00007814"},{"key":"2025083112420304000_9.1.e001272.12","unstructured":"Kjellstr\u00f6m BWM DH , Hesselstrand R . Swedish Pulmonary Arterial Hypertension Registry annual report 2019; 2020."},{"key":"2025083112420304000_9.1.e001272.13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2045894018780521","article-title":"Characteristics and survival data from Latvian pulmonary hypertension registry: comparison of prospective pulmonary hypertension registries in Europe","volume":"8","author":"Skride","year":"2018","journal-title":"Pulm Circ"},{"key":"2025083112420304000_9.1.e001272.14","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00092306"},{"key":"2025083112420304000_9.1.e001272.15","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-14-45"},{"key":"2025083112420304000_9.1.e001272.16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2045894020977300","article-title":"Epidemiology of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: identification of the most accurate estimates from a systematic literature review","volume":"11","author":"Leber","year":"2021","journal-title":"Pulm Circ"},{"key":"2025083112420304000_9.1.e001272.17","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00078411"},{"key":"2025083112420304000_9.1.e001272.18","first-page":"1","article-title":"Characteristics of chronic thromboembolic pulmonary hypertension in Ireland","volume":"11","author":"Cullivan","year":"2021","journal-title":"Pulm Circ"},{"key":"2025083112420304000_9.1.e001272.19","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203301"},{"key":"2025083112420304000_9.1.e001272.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2019.08.001"},{"key":"2025083112420304000_9.1.e001272.21","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-107-2-216"},{"key":"2025083112420304000_9.1.e001272.22","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00057010"},{"key":"2025083112420304000_9.1.e001272.23","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00101211"},{"key":"2025083112420304000_9.1.e001272.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2017.02.016"},{"key":"2025083112420304000_9.1.e001272.25","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.ijcard.2015.11.001","article-title":"Incidence and prevalence of pulmonary arterial hypertension in Germany","volume":"203","author":"Hoeper","year":"2016","journal-title":"Int J Cardiol"},{"key":"2025083112420304000_9.1.e001272.26","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1086\/681270","article-title":"Survival in an incident cohort of patients with pulmonary arterial hypertension in Denmark","volume":"5","author":"Korsholm","year":"2015","journal-title":"Pulm Circ"},{"key":"2025083112420304000_9.1.e001272.27","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00007311"},{"key":"2025083112420304000_9.1.e001272.28","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.chest.2015.11.008","article-title":"Effect of age on phenotype and outcomes in pulmonary arterial hypertension trials","volume":"149","author":"Rose","year":"2016","journal-title":"Chest"},{"key":"2025083112420304000_9.1.e001272.29","doi-asserted-by":"crossref","first-page":"1702310","DOI":"10.1183\/13993003.02310-2017","article-title":"Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension","volume":"51","author":"Hjalmarsson","year":"2018","journal-title":"Eur Respir J"},{"key":"2025083112420304000_9.1.e001272.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2009.07.005"},{"key":"2025083112420304000_9.1.e001272.31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2045894019894531","article-title":"The prognostic value of DLCO and pulmonary blood flow in patients with pulmonary hypertension","volume":"9","author":"Stadler","year":"2019","journal-title":"Pulm Circ"},{"key":"2025083112420304000_9.1.e001272.32","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/14017431.2016.1185532","article-title":"Characteristics and survival of adult Swedish PAH and CTEPH patients 2000-2014","volume":"50","author":"R\u00e5degran","year":"2016","journal-title":"Scand Cardiovasc J"},{"key":"2025083112420304000_9.1.e001272.33","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200510-1668OC"},{"key":"2025083112420304000_9.1.e001272.34","doi-asserted-by":"crossref","unstructured":"Baptista R , Meireles J , Agapito A . Pulmonary hypertension in Portugal: first data from a nationwide registry. Biomed Res Int 2013. 2013;489574.doi:10.1155\/2013\/489574","DOI":"10.1155\/2013\/489574"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2022-001272","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T19:42:13Z","timestamp":1756669333000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2022-001272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,6,29]]},"published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10.1136\/bmjresp-2022-001272"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2022-001272","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6]]}}}